Pharmaceuticals - Community Register


Community register of orphan medicinal products


Product information


EU orphan designation number: EU/3/09/659   
Active ingredient: Tosedostat
Indication: Treatment of acute myeloid leukaemia
Sponsor: Chroma Therapeutics Ltd
93 Milton Park, Abingdon, Oxfordshire OX14 4RY, United Kingdom

   Public summary of scientific opinion    

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
28/07/2009 Centralised Orphan - Designation EMEA/OD/028/09 (2009)6033 of 24/07/2009